| |
| |
|
| Insider
Information: |
Cohen Raymond W |
| Relationship: |
|
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
284,273 |
|
|
Indirect Shares
|
692,151 |
|
|
| Direct
Value |
$13,320,755 |
|
|
|
Indirect Value
|
$46,436,411 |
|
|
| Total
Shares |
976,424 |
|
|
| Total
Value |
$59,757,165 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
8
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 88.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cardiac Science Corp |
CSCX |
Director |
2009-05-22 |
13,825 |
|
0 |
Premium* |
|
|
Spectrum Pharmaceuticals Inc |
SPPI |
Director |
2019-06-20 |
53,850 |
2013-12-13 |
0 |
Premium* |
|
|
Biolife Solutions Inc |
BLFS |
Director |
2021-07-12 |
27,763 |
2014-05-20 |
0 |
Premium* |
|
|
Axonics Modulation Technologies,... |
AXNX |
|
2024-01-31 |
188,835 |
2019-08-06 |
692,151 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
81 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BLFS |
Biolife Solutions Inc |
Director |
• • – |
2019-08-15 |
4 |
AS |
$17.98 |
$96,319 |
D/D |
(5,357) |
23,388 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
• • – |
2020-01-13 |
4 |
AS |
$31.98 |
$319,800 |
D/D |
(10,000) |
608,391 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
• • – |
2020-02-13 |
4 |
AS |
$33.21 |
$332,065 |
D/D |
(10,000) |
542,058 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
• • – |
2020-03-16 |
4 |
AS |
$20.87 |
$864,639 |
D/D |
(41,224) |
542,058 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
• • – |
2020-07-13 |
4 |
AS |
$40.34 |
$1,008,761 |
D/D |
(25,000) |
517,058 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
• • – |
2020-07-14 |
4 |
AS |
$36.49 |
$912,273 |
D/D |
(25,000) |
492,058 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
• • – |
2020-07-15 |
4 |
AS |
$38.55 |
$981,327 |
D/D |
(25,000) |
467,058 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
• • – |
2020-07-16 |
4 |
AS |
$39.65 |
$991,268 |
D/D |
(25,000) |
442,058 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
• • – |
2020-08-07 |
4 |
AS |
$41.82 |
$839,583 |
D/D |
(20,000) |
422,058 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
• • – |
2020-08-11 |
4 |
AS |
$40.95 |
$1,053,636 |
D/D |
(25,000) |
397,058 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
• • – |
2021-05-10 |
4 |
AS |
$52.98 |
$1,818,158 |
D/D |
(33,833) |
350,773 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
• • – |
2021-05-18 |
4 |
AS |
$55.00 |
$1,805,815 |
D/D |
(32,833) |
317,940 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
• • – |
2021-06-08 |
4 |
AS |
$60.00 |
$1,999,980 |
D/D |
(33,333) |
284,607 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
• • – |
2021-09-09 |
4 |
AS |
$77.11 |
$3,855,350 |
D/D |
(50,000) |
234,607 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
• • – |
2022-03-14 |
4 |
AS |
$50.42 |
$2,641,148 |
D/D |
(50,000) |
243,635 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
• • – |
2022-03-29 |
4 |
AS |
$60.00 |
$3,000,000 |
D/D |
(50,000) |
193,635 |
0 |
% |
|
| AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
• • – |
2022-08-08 |
4 |
AS |
$69.50 |
$3,099,326 |
D/D |
(44,000) |
149,635 |
0 |
% |
|
| BLFS |
Biolife Solutions Inc |
Chairman |
• • – |
2014-05-20 |
4 |
B |
$2.39 |
$9,560 |
D/D |
4,000 |
7,216 |
2.39 |
- |
|
| BLFS |
Biolife Solutions Inc |
Chairman |
• • – |
2014-08-08 |
4 |
B |
$2.48 |
$3,100 |
D/D |
1,250 |
8,466 |
2.31 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Chief Executive Officer |
• • – |
2019-08-06 |
4 |
B |
$30.41 |
$106,439 |
D/D |
3,500 |
683,391 |
0.01 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Director |
– • – |
2015-07-07 |
4 |
D |
$6.96 |
$4,350 |
D/D |
(625) |
29,375 |
0 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Director |
– • – |
2016-06-27 |
4 |
D |
$6.47 |
$4,044 |
D/D |
(625) |
28,750 |
0 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Director |
– • – |
2016-06-28 |
4 |
D |
$6.33 |
$15,825 |
D/D |
(2,500) |
26,250 |
0 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Director |
– • – |
2017-06-13 |
4 |
D |
$6.48 |
$16,200 |
D/D |
(2,500) |
33,750 |
0 |
- |
|
| SPPI |
Spectrum Pharmaceuticals ... |
Director |
– • – |
2017-06-27 |
4 |
D |
$7.54 |
$4,713 |
D/D |
(625) |
43,125 |
0 |
- |
|
81 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
